COVID-19 Research Database Announces Over 1,500 Researchers Registered And Over 100 Studies in Progress
The COVID-19 Research Database, a pro-bono initiative led by numerous leading healthcare organizations, including Change Healthcare, Datavant, the Health Care Cost Institute (HCCI), Healthjump, Medidata (a Dassault Systèmes company), Mirador Analytics, Office Ally, SAS, StataCorp, Snowflake, Symphony Health, and Veradigm, today announced that it has over 1,500 researchers registered and over 100 studies underway.
"In a crisis situation, in which the country finds itself without a system for collecting, pooling and linking data, this effort within the private sector is a game changer, and a model for future efforts to solve national clinical and public health challenges," said Dr. Mark Cullen, professor of medicine at Stanford and chair of the Scientific Steering Committee.
Researchers from more than 350 different institutions have registered, including all of the country's 30 top medical schools, the Centers for Disease Control and Prevention, the U.S. Food and Drug Administration, and the National Institutes of Health. Research groups are working on studies ranging from optimal policy responses to the pandemic to how the pandemic has changed the provision of non-COVID-19 related services.
Sample publications have investigated:
"The type of near-real-time, high-frequency and comprehensive data that researchers can access through the COVID-19 Research Database is unprecedented," said Dr. Kosali Simon, the Herman B. Wells Endowed Professor in health economics at the O'Neill School of Public and Environmental Affairs at Indiana University. "It's enabling research that would otherwise have taken years to complete, for guiding policy and practitioner decisions that needed to be made yesterday."
In addition, the database effort has identified and implemented new ways to better utilize real-world data, which will continue to be valuable post-pandemic and in studying other diseases. The database effort has introduced an innovative new data solution allowing many data sets to be joined together without compromising patient privacy. This will create longer and richer longitudinal histories, which enable researchers to better understand the impacts of the current pandemic and the long-term impacts for patients' health. Mirador Analytics provided the expert determination services for the creation of the data solution along with Medidata, a Dassault Systemes company, which built the data architecture and provisioned environment to enable researchers to access the database. The Health Care Cost Institute will continue to manage the researcher application process and data governance for the effort.
Organizations participating in the COVID-19 Research Database include AnalyticsIQ, Arcadia.io, Berkeley Research Group, Change Healthcare, Datavant, Elsevier, Eurofins Viracor, Glooko, Health Care Cost Institute, Healthjump, HealthWise Data, Helix, Medidata, a Dassault Systemes company, Mirador Analytics, Munich Re Life US, Office Ally, Ovation, Panalgo, Parexel, PointClickCare, Prognos Health, QIAGEN, SAS, Snowflake, StataCorp, Sumitomo Dainippon Pharma, Symphony Health, Veradigm, and Verana Health.
Read Press Release >>
Source: Datavant / Newswire